Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2918589rdf:typepubmed:Citationlld:pubmed
pubmed-article:2918589lifeskim:mentionsumls-concept:C0242350lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C0030350lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C0030847lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C0002335lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C0031448lld:lifeskim
pubmed-article:2918589lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2918589pubmed:issue3lld:pubmed
pubmed-article:2918589pubmed:dateCreated1989-3-30lld:pubmed
pubmed-article:2918589pubmed:abstractTextThe use of intracavernous prostaglandin E1 was studied in 48 organically impotent men. Eight men with previous chemical priapism did not have chemically induced priapism at up to 4 times the minimum effective dose of prostaglandin E1. Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1. A total of 25 men received intracavernous prostaglandin E1 and phentolamine plus papaverine in a double-blind fashion. Erections with prostaglandin E1 were equal or superior to those with phentolamine plus papaverine in each case.lld:pubmed
pubmed-article:2918589pubmed:languageenglld:pubmed
pubmed-article:2918589pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2918589pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2918589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2918589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2918589pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2918589pubmed:statusMEDLINElld:pubmed
pubmed-article:2918589pubmed:monthMarlld:pubmed
pubmed-article:2918589pubmed:issn0022-5347lld:pubmed
pubmed-article:2918589pubmed:authorpubmed-author:SzaszGGlld:pubmed
pubmed-article:2918589pubmed:authorpubmed-author:LeeL MLMlld:pubmed
pubmed-article:2918589pubmed:authorpubmed-author:StevensonR...lld:pubmed
pubmed-article:2918589pubmed:issnTypePrintlld:pubmed
pubmed-article:2918589pubmed:volume141lld:pubmed
pubmed-article:2918589pubmed:ownerNLMlld:pubmed
pubmed-article:2918589pubmed:authorsCompleteYlld:pubmed
pubmed-article:2918589pubmed:pagination549-50lld:pubmed
pubmed-article:2918589pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:meshHeadingpubmed-meshheading:2918589-...lld:pubmed
pubmed-article:2918589pubmed:year1989lld:pubmed
pubmed-article:2918589pubmed:articleTitleProstaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.lld:pubmed
pubmed-article:2918589pubmed:affiliationDepartment of Surgery, University of British Columbia, Vancouver, Canada.lld:pubmed
pubmed-article:2918589pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2918589pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2918589pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2918589pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2918589lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2918589lld:pubmed